Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
28
DOUG Quote, Financials, Valuation and Earnings
Last price:
$1.55
Seasonality move
:
-29.62%
Day range:
$1.53 - $1.63
52-week range:
$1.00 - $3.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.14x
P/B ratio:
0.82x
Volume:
857.4K
Avg. volume:
1.1M
1-year change:
-45.92%
Market cap:
$141.8M
Revenue:
$955.6M
EPS (TTM):
-$1.03
Analysts' Opinion
-
Consensus RatingDouglas Elliman has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Douglas Elliman has an estimated upside of 101.26% from its current price of $1.59.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $1.59.
Fair Value
-
According to the consensus of 0 analysts, Douglas Elliman has 101.26% upside to fair value with a price target of -- per share.
DOUG vs. S&P 500
-
Over the past 5 trading days, Douglas Elliman has underperformed the S&P 500 by -7.58% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Douglas Elliman does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Douglas Elliman has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Douglas Elliman reported revenues of $266.3M.
Earnings Growth
-
Douglas Elliman earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Douglas Elliman reported earnings per share of -$0.33.
Enterprise value:
22.8M
EV / Invested capital:
0.11x
Price / LTM sales:
0.14x
EV / EBIT:
--
EV / Revenue:
0.02x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
-0.92x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$242.4M
Return On Assets:
-17.51%
Net Income Margin (TTM):
-8.81%
Return On Equity:
-40.59%
Return On Invested Capital:
-39.38%
Operating Margin:
-2.78%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $1.3B | $948.8M | $966.4M | $251.5M | $266.3M | |
| Gross Profit | $402.6M | $251.7M | $242.4M | $65.7M | $67.2M | |
| Operating Income | $36.5M | -$60.9M | -$57.3M | -$8.6M | -$7.4M | |
| EBITDA | $46.7M | -$51.2M | -$70.4M | -$5M | -$24.1M | |
| Diluted EPS | $0.39 | -$0.57 | -$1.03 | -$0.06 | -$0.33 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $218.5M | $257M | $197M | $205.5M | |
| Total Assets | -- | $534.4M | $580.1M | $511.1M | $502.7M | |
| Current Liabilities | -- | $119.4M | $103M | $93M | $89.7M | |
| Total Liabilities | -- | $297.7M | $289.4M | $263.4M | $328.7M | |
| Total Equity | -- | $236.7M | $290.6M | $247.7M | $173.9M | |
| Total Debt | -- | $15.8M | $3.3M | -- | $32.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $39.6M | -$47.7M | -$19.6M | -$4.6M | $9M | |
| Cash From Investing | -$12M | -$8.6M | -$1.8M | -$776K | -$1.4M | |
| Cash From Financing | $1.4M | -$11.5M | $44.8M | -- | $46.8M | |
| Free Cash Flow | $32M | -$55.4M | -$24.7M | -$5.4M | $7.7M | |
DOUG
Sector
Market Cap
$141.8M
$1.1B
Price % of 52-Week High
50.32%
83.08%
Dividend Yield
0%
3.41%
Shareholder Yield
--
3.4%
1-Year Price Total Return
-45.92%
-4.96%
Beta (5-Year)
--
0.881
Dividend yield:
0%
Annualized payout:
$0.05
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$1.70
200-day SMA
Sell
Level
$1.64
Bollinger Bands (100)
Sell
Level
1.64 - 2.2
Chaikin Money Flow
Sell
Level
-30.1M
20-day SMA
Sell
Level
$2.04
Relative Strength Index (RSI14)
Sell
Level
33.14
ADX Line
Sell
Level
30.96
Williams %R
Buy
Level
-93.617
50-day SMA
Sell
Level
$2.01
MACD (12, 26)
Sell
Level
-0.15
25-day Aroon Oscillator
Sell
Level
-84
On Balance Volume
Sell
Level
-40.2M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1909)
Sell
CA Score
(Annual)
Level (-0.3688)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (1.0065)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees.
Stock Forecast FAQ
In the current month, DOUG has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DOUG average analyst price target in the past 3 months is --.
-
Where Will Douglas Elliman Stock Be In 1 Year?
According to analysts, the consensus estimate is that Douglas Elliman share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Douglas Elliman?
Analysts are divided on their view about Douglas Elliman share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Douglas Elliman is a Sell and believe this share price will drop from its current level to --.
-
What Is Douglas Elliman's Price Target?
The price target for Douglas Elliman over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DOUG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Douglas Elliman is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of DOUG?
You can purchase shares of Douglas Elliman via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Douglas Elliman shares.
-
What Is The Douglas Elliman Share Price Today?
Douglas Elliman was last trading at $1.55 per share. This represents the most recent stock quote for Douglas Elliman. Yesterday, Douglas Elliman closed at $1.59 per share.
-
How To Buy Douglas Elliman Stock Online?
In order to purchase Douglas Elliman stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
